REGENERATIVE OPHTHALMOLOGY
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Jan 2019)
What this means for you
This application is over — abandoned 14 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87081955
- Mark type
- Design + words
- Filed
- 23 Jun 2016
- Published for opposition
- 18 Apr 2017
- Abandoned
- 14 Jan 2019
- Attorney of record
- Christina M. Licursi,
Goods and services
- Class 001 — Chemicals: Tissues, cells, proteins, small molecule drugs, cell and protein extracts, components of cells and proteins, and cell and protein culture media for medical and scientific research
- Class 005 — Pharmaceuticals: Cells, proteins, small molecule drugs, cell and protein extracts, components of cells and proteins, and cell and protein culture media for the treatment of eye diseases and conditions for medical and veterinary purposes
Owner
- Astellas Institute for Regenerative Medicine, Marlborough, MA, US
- Astellas Institute for Regenerative Medicine, Marlborough, MA, US
Prosecution history
- 14 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jun 2018 — SOU EXTENSION 2 GRANTED
- 11 Jun 2018 — SOU EXTENSION 2 FILED
- 11 Jun 2018 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2017 — SOU EXTENSION 1 GRANTED
- 13 Dec 2017 — SOU EXTENSION 1 FILED
- 13 Dec 2017 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Apr 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Apr 2017 — PUBLISHED FOR OPPOSITION
- 29 Mar 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER